We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Stephen Kelly/PA Wire/Press Association Images

Aspirin a day can help prevent and even treat cancer, study suggests

Low doses of the common painkiller significantly reduced the risk of cancers developing and spreading in the body.

TAKING ONE ASPIRIN every day can significantly reduce an individual’s risk of developing cancer and help in treating the disease, new research has suggested.

The papers published UK medical journal The Lancet appear to show that low doses of the common painkiller can help stop tumours spreading from one area of the body to others.

Patients taking between 75mg and 300mg of aspirin a day saw their risk of cancer drop by 25 per cent within three years. By five years, the decrease was 37 per cent, the BBC reports.

One dramatic finding of the study was that patients with localised colorectal cancer saw the risk of having their tumours spread drop by 74 per cent with daily low-dose aspirin, according to WebMD.

Many older people already take aspirin regularly for blood pressure disorders.

The research involved analysis of results from 51 trials, comprising more than 77,000 patients altogether.

Study leader Professor Peter Rothwell told the Daily Telegraph: “These data do push the argument in favour of taking daily low-dose aspirin, particularly if you have a family history of heart disease or cancer.”

Previous studies led by Rothwell had shown similar effects but over a much longer time-frame, with the decrease in cancer risk only apparent around ten years after beginning regular doses.

Your Voice
Readers Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.